Immunoproliferative Small Intestinal Disease

This is a rare disease affecting the small intestine. It involves an overgrowth of immune cells (lymphocytes) in the small intestine and nearby lymph nodes. These cells make an abnormal protein, and it often leads to problems like diarrhea, weight loss, and poor absorption of nutrients.

Condition

What people with Immunoproliferative Small Intestinal Disease report

Every report comes from a Lived member, sent anonymously.

Have you tried Tetracycline for Immunoproliferative Small Intestinal Disease?

NameHow it went

About Immunoproliferative Small Intestinal Disease

What It Is

Immunoproliferative small intestinal disease (IPSID) is a rare type of lymphoma, a cancer of immune cells, that starts in the lining of the small intestine. A single family of antibody-making B cells multiplies and crowds the intestinal wall and nearby lymph nodes. The damaged lining can no longer absorb food well, so the main effects are long-lasting watery diarrhea, greasy stools, belly pain and weight loss, which can lead to serious malnutrition. IPSID is a form of marginal zone lymphoma, a group of slow-growing lymphomas that arise in the immune tissue of the body's mucous membranes. In its early stage it can behave more like a chronic inflammatory disease, but without treatment it can turn into a fast-growing, aggressive lymphoma. It was first described in the Mediterranean region and was once called Mediterranean lymphoma. It is also known as alpha heavy chain disease, because the abnormal cells often release an incomplete antibody fragment (the alpha heavy chain) into the blood.

Causes & Risk Factors

The leading explanation is long-term stimulation of the immune system in the gut. Repeated or persistent intestinal infections keep antibody-making cells working, and over time one group of those cells can grow out of control. This is why IPSID has been linked with poor sanitation, lack of clean water and low income, and why it has become less common where those conditions improved. A bacterium called Campylobacter jejuni, a common cause of food poisoning, is the organism most often found in people with IPSID, but researchers have not proved that it causes the disease. Most cases have been reported in the Middle East and Mediterranean, Africa and Asia, with occasional cases elsewhere. It usually appears in teenagers and young adults, and men are affected more often than women. Some families seem more prone to it, but no clear inherited cause has been identified.

How It's Diagnosed

Because IPSID is rare and its symptoms resemble celiac disease, chronic intestinal infections, tuberculosis of the intestine and inflammatory bowel disease, diagnosis often takes many months. A specialist usually suspects it in a young adult with unexplained long-term diarrhea and weight loss, especially someone from a region where it is more common. The diagnosis is made from tissue. An endoscopy, a flexible camera passed through the mouth into the small intestine, lets the doctor take several biopsies, and sometimes surgery is needed to sample deeper layers of the bowel and the lymph nodes. Under the microscope, a pathologist looks for flattened intestinal lining packed with abnormal plasma cells and checks whether those cells make the incomplete alpha heavy chain. A blood test called immunoelectrophoresis can find this protein in about 7 in 10 people with IPSID, so a negative result does not rule it out. Imaging scans of the abdomen, such as computed tomography (a detailed X-ray scan) or positron emission tomography (a scan that highlights active cancer cells), show how much of the bowel and how many lymph nodes are involved. Blood tests check for anemia, low protein and vitamin levels, and salt imbalances caused by poor absorption. Together these findings place the disease in a stage, from early (A) to advanced lymphoma (C), which guides treatment.

Treatment Options

Treatment depends on the stage, and it is usually directed by a blood cancer specialist (hematologist-oncologist) together with a gastroenterologist. Because IPSID is rare, there are no clinical trials or formal guidelines, and the advice comes from case reports and small series. In early disease, a long course of antibiotics, typically tetracycline with or without metronidazole for about six months, can make the disease go into remission by removing the infections thought to drive it. Many people improve, but the disease returns in a large share of them within five years. If there is no response after six months, or the disease has not cleared within a year, doctors usually repeat the biopsy and consider chemotherapy. Intermediate disease may be treated with antibiotics plus milder chemotherapy. Advanced disease is treated like an aggressive lymphoma, usually with several cycles of combination chemotherapy such as CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone), along with antibiotics, with the aim of cure. Chemotherapy has significant side effects of its own, which the treating team monitors and manages. Radiation can shrink a bulky tumor quickly, surgery is used for complications such as a blocked or torn bowel, and a stem cell transplant using the person's own cells may be considered if the disease returns or does not respond. At every stage, restoring nutrition is part of treatment: correcting salt and mineral levels, a high-protein diet, and replacing vitamins and protein help the body recover and tolerate therapy.

What to Expect

IPSID often develops slowly. Many people look back on years of milder, on-and-off digestive symptoms before diagnosis. Once treatment starts, diarrhea usually eases and weight returns as the intestinal lining heals, though recovering from serious malnutrition can take months. Some people notice that milk products make their symptoms worse. The outlook depends heavily on stage. Early disease often responds to antibiotics, but relapse is common, so regular follow-up is important even when someone feels well. Doctors track progress through symptoms, weight, scans and repeat biopsies, and sometimes the blood level of the alpha heavy chain, although that marker is not always reliable. Advanced disease requires months of chemotherapy, and responses vary widely. Because so few cases have been studied, it is hard to predict how quickly or whether an individual's disease will progress, which is one reason ongoing care with a specialist team matters.

When to Seek Help

Arrange a medical evaluation for diarrhea that lasts for weeks, unexplained weight loss, or greasy, foul-smelling stools, particularly if you have lived in a region where intestinal infections are common. If you already have IPSID, contact your care team promptly if diarrhea or weight loss returns after treatment, or if you develop muscle cramps or spasms in the hands and feet, dizziness or very low urine output, which can signal dangerous mineral or fluid losses. Advanced IPSID can block, tear or bleed from the bowel. Seek emergency care for sudden or severe belly pain, a swollen belly with repeated vomiting, or black or bloody stools.

Questions to Ask Your Doctor

  1. 1.What stage is my disease, and how does that change the treatment you recommend?
  2. 2.How will we know whether the antibiotics are working, and when would we move to chemotherapy?
  3. 3.What can I do to rebuild my nutrition, and do I need vitamin, mineral or protein replacement?
  4. 4.How often will I need scans, blood tests or repeat biopsies after treatment to check for relapse?
  5. 5.Should I be seen at a center with experience treating this kind of lymphoma?

Last reviewed • Oct 2026

Educational content, not medical advice.